Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2019
Price : $35 *
At a glance
- Drugs B cell lymphoma vaccine (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- Sponsors XEME Biopharma
- 15 Jan 2019 Last checked against ClinicalTrials.gov record.
- 08 Jan 2019 Planned End Date changed from 1 Jun 2020 to 1 Jan 2023.
- 08 Jan 2019 Planned primary completion date changed from 1 May 2020 to 1 Jan 2022.